ABK Biomedical
Developer of a microsphere product designed to improve the treatment of hypervascular tumors. The company's product is a novel radiopaque bland embolic and beta radiation emitting agent that helps to ...
Interested in buying or selling ABK Biomedical shares?
Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.
Valuation
$0
Share Price
N/A
Total Raised
$121.7M
Last Round
N/A